0001179110-22-003137.txt : 20220525 0001179110-22-003137.hdr.sgml : 20220525 20220525165803 ACCESSION NUMBER: 0001179110-22-003137 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220523 FILED AS OF DATE: 20220525 DATE AS OF CHANGE: 20220525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEVERINO MICHAEL CENTRAL INDEX KEY: 0001609447 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 22963844 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2022-05-23 0 0001551152 AbbVie Inc. ABBV 0001609447 SEVERINO MICHAEL 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 Vice Chairman Common Stock, $0.01 par value 2022-05-23 4 M 0 46320 114.36 A 198423 D Common Stock, $0.01 par value 2022-05-23 4 M 0 11742 93.50 A 210165 D Common Stock, $0.01 par value 2022-05-23 4 M 0 21739 105.92 A 231904 D Common Stock, $0.01 par value 2022-05-23 4 S 0 68196 150.79 D 163708 D Common Stock, $0.01 par value 2022-05-23 4 S 0 11605 151.53 D 152103 D Option (Right to Buy) 114.36 2022-05-23 4 M 0 46320 114.36 D 2019-02-15 2028-02-14 Common Stock 46320 0 D Option (Right to Buy) 93.50 2022-05-23 4 M 0 11742 93.50 D 2021-02-20 2030-02-19 Common Stock 11742 38188 D Option (Right to Buy) 105.92 2022-05-23 4 M 0 21739 105.92 D 2022-02-18 2031-02-17 Common Stock 21739 43478 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.13 to $151.12 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.13 to $151.58 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Steven L. Scrogham, attorney-in-fact for Michael Severino 2022-05-25